Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region
- PMID: 23894402
- PMCID: PMC3718800
- DOI: 10.1371/journal.pone.0069031
Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region
Abstract
Background: We have previously proposed triosephosphate isomerase of Giardia lamblia (GlTIM) as a target for rational drug design against giardiasis, one of the most common parasitic infections in humans. Since the enzyme exists in the parasite and the host, selective inhibition is a major challenge because essential regions that could be considered molecular targets are highly conserved. Previous biochemical evidence showed that chemical modification of the non-conserved non-catalytic cysteine 222 (C222) inactivates specifically GlTIM. The inactivation correlates with the physicochemical properties of the modifying agent: addition of a non-polar, small chemical group at C222 reduces the enzyme activity by one half, whereas negatively charged, large chemical groups cause full inactivation.
Results: In this work we used mutagenesis to extend our understanding of the functional and structural effects triggered by modification of C222. To this end, six GlTIM C222 mutants with side chains having diverse physicochemical characteristics were characterized. We found that the polarity, charge and volume of the side chain in the mutant amino acid differentially alter the activity, the affinity, the stability and the structure of the enzyme. The data show that mutagenesis of C222 mimics the effects of chemical modification. The crystallographic structure of C222D GlTIM shows the disruptive effects of introducing a negative charge at position 222: the mutation perturbs loop 7, a region of the enzyme whose interactions with the catalytic loop 6 are essential for TIM stability, ligand binding and catalysis. The amino acid sequence of TIM in phylogenetic diverse groups indicates that C222 and its surrounding residues are poorly conserved, supporting the proposal that this region is a good target for specific drug design.
Conclusions: The results demonstrate that it is possible to inhibit species-specifically a ubiquitous, structurally highly conserved enzyme by modification of a non-conserved, non-catalytic residue through long-range perturbation of essential regions.
Conflict of interest statement
Figures








Similar articles
-
Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential.Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):425-432. doi: 10.1016/j.ijpddr.2017.11.003. Epub 2017 Dec 1. Int J Parasitol Drugs Drug Resist. 2017. PMID: 29197728 Free PMC article.
-
Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design.Proteins. 2011 Sep;79(9):2711-24. doi: 10.1002/prot.23100. Epub 2011 Jul 22. Proteins. 2011. PMID: 21786322
-
Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity.J Mol Biol. 2007 Jan 19;365(3):752-63. doi: 10.1016/j.jmb.2006.10.053. Epub 2006 Oct 21. J Mol Biol. 2007. PMID: 17095008
-
A guide to the effects of a large portion of the residues of triosephosphate isomerase on catalysis, stability, druggability, and human disease.Proteins. 2017 Jul;85(7):1190-1211. doi: 10.1002/prot.25299. Epub 2017 Apr 27. Proteins. 2017. PMID: 28378917 Review.
-
Triosephosphate isomerase: a highly evolved biocatalyst.Cell Mol Life Sci. 2010 Dec;67(23):3961-82. doi: 10.1007/s00018-010-0473-9. Epub 2010 Aug 7. Cell Mol Life Sci. 2010. PMID: 20694739 Free PMC article. Review.
Cited by
-
Methylglyoxal-Induced Modifications in Human Triosephosphate Isomerase: Structural and Functional Repercussions of Specific Mutations.Molecules. 2024 Oct 25;29(21):5047. doi: 10.3390/molecules29215047. Molecules. 2024. PMID: 39519689 Free PMC article.
-
Enhanced Antigiardial Effect of Omeprazole Analog Benzimidazole Compounds.Molecules. 2020 Sep 1;25(17):3979. doi: 10.3390/molecules25173979. Molecules. 2020. PMID: 32882836 Free PMC article.
-
Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini.Sci Rep. 2018 Oct 10;8(1):15075. doi: 10.1038/s41598-018-33479-8. Sci Rep. 2018. PMID: 30305716 Free PMC article.
-
Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential.Int J Parasitol Drugs Drug Resist. 2017 Dec;7(3):425-432. doi: 10.1016/j.ijpddr.2017.11.003. Epub 2017 Dec 1. Int J Parasitol Drugs Drug Resist. 2017. PMID: 29197728 Free PMC article.
-
Crystal structures of Triosephosphate Isomerases from Taenia solium and Schistosoma mansoni provide insights for vaccine rationale and drug design against helminth parasites.PLoS Negl Trop Dis. 2020 Jan 10;14(1):e0007815. doi: 10.1371/journal.pntd.0007815. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31923219 Free PMC article.
References
-
- García-Torres I, Gómez-Manzo S, Castillo-Villanueva A, Hernández-Alcántara G, Enríquez-Flores S, et al... (2012) Novel therapeutic approaches for protozoan parasitic diseases. In: Téllez-Valencia A, Pedraza-Reyes M, editors. Current Topics of Drug Design in Parasitic and Bacterial Diseases. Kerala; India: Transworld Research Network. 49–66.
-
- Ouzounis C, Kyrpides N (1996) The emergence of major cellular processes in evolution. FEBS Lett. 390: 119–123. - PubMed
-
- Gómez-Puyou A, Saavedra-Lira E, Becker I, Zubillaga RA, Rojo-Domínguez A, et al. (1995) Using evolutionary changes to achieve species-specific inhibition of enzyme action–studies with triosephosphate isomerase. Chem Biol. 2: 847–855. - PubMed
-
- Maithal K, Ravindra G, Balaram H, Balaram P (2002) Inhibition of plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. Electrospray ionization mass spectrometric analysis of differential cysteine reactivities. J Biol Chem. 277: 25106–25114. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources